CoImmune
Durham
About CoImmune
CoImmune is a cell therapy company designed to leverage its own immune system to fight disease. It is a clinical-stage immuno-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $45.0M
- Last round: Series Unknown (Jan 2023)
- Website: coimmune.com
- Phone: +1 919 287 6300
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/coimmune-38304 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.